Literature DB >> 5703936

[Comparative study of drugs inhibiting the contractile response of isolated vessels of human and animal origin].

T Godfraind, P Polster.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 5703936

Source DB:  PubMed          Journal:  Therapie        ISSN: 0040-5957            Impact factor:   2.070


× No keyword cloud information.
  6 in total

Review 1.  Antioxidant effects and the therapeutic mode of action of calcium channel blockers in hypertension and atherosclerosis.

Authors:  Théophile Godfraind
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 2.  'Cerebroactive' drugs. Clinical pharmacology and therapeutic role in cerebrovascular disorders.

Authors:  A Spagnoli; G Tognoni
Journal:  Drugs       Date:  1983-07       Impact factor: 9.546

3.  SR 33557, a novel calcium-antagonist: interaction with [3H]-(+/-)-nitrendipine and [3H]-(-)-desmethoxy-verapamil binding sites in cerebral membranes.

Authors:  P Nokin; M Clinet; P Polster; P Beaufort; L Meysmans; J Gougat; P Chatelain
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

4.  Blockade or reversal of the contraction induced by calcium and adrenaline in depolarized arterial smooth muscle.

Authors:  T Godfraind; A Kaba
Journal:  Br J Pharmacol       Date:  1969-07       Impact factor: 8.739

Review 5.  Discovery and Development of Calcium Channel Blockers.

Authors:  Théophile Godfraind
Journal:  Front Pharmacol       Date:  2017-05-29       Impact factor: 5.810

Review 6.  Calcium Channels in the Heart: Disease States and Drugs.

Authors:  Kajol Shah; Sarah Seeley; Castin Schulz; Jacqueline Fisher; Shubha Gururaja Rao
Journal:  Cells       Date:  2022-03-10       Impact factor: 6.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.